These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3771353)

  • 21. Prospects for prevention of bronchiolitis caused by respiratory syncytial virus.
    Chanock RM; Richardson LS; Belshe RB; Kim HW; Parrott RH
    Pediatr Res; 1977 Mar; 11(3 Pt 2):264-7. PubMed ID: 846778
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V.
    Vangeel I; Ioannou F; Riegler L; Salt JS; Harmeyer SS
    Vet J; 2009 Jan; 179(1):101-8. PubMed ID: 17931918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to modified live and killed multivalent viral vaccine in regularly vaccinated, fresh dairy cows.
    Dubovi EJ; Gröhn YT; Brunner MA; Hertl JA
    Vet Ther; 2000; 1(1):49-58. PubMed ID: 19757565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological responses in calves to vaccines against bovine respiratory syncytial, infectious bovine rhinotracheitis, bovine viral diarrhoea and parainfluenza-3 viruses.
    Tollis M; Di Trani L; Cordioli P; Vignolo E; Di Pasquale I
    Dev Biol Stand; 1996; 86():147-56. PubMed ID: 8785944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human and bovine respiratory syncytial virus vaccine research and development.
    Meyer G; Deplanche M; Schelcher F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):191-225. PubMed ID: 17720245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in respiratory syncytial virus vaccine development.
    Kneyber MC; Kimpen JL
    Curr Opin Investig Drugs; 2004 Feb; 5(2):163-70. PubMed ID: 15043390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated immune response in cattle to bovine respiratory syncytial virus.
    Field EW; Smith MH
    Am J Vet Res; 1984 Aug; 45(8):1641-3. PubMed ID: 6383149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection.
    Johnson TR; Graham BS
    Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serologic studies of bovine respiratory syncytial virus in Minnesota cattle.
    Baker JC; Ames TR; Markham RJ
    Am J Vet Res; 1985 Apr; 46(4):891-2. PubMed ID: 4014838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates.
    Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB
    Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory syncytial virus--how soon will we have a vaccine?
    Toms GL
    Arch Dis Child; 1995 Jan; 72(1):1-3. PubMed ID: 7717728
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new vaccine against airway infections caused by RS-virus].
    van der Veen J
    Ned Tijdschr Geneeskd; 1979 Jan; 123(1):15-6. PubMed ID: 759961
    [No Abstract]   [Full Text] [Related]  

  • 38. Respiratory syncytial virus vaccines.
    Karron RA; Ambrosino DM
    Pediatr Infect Dis J; 1998 Oct; 17(10):919-20. PubMed ID: 9802636
    [No Abstract]   [Full Text] [Related]  

  • 39. The possible use of temperature-sensitive conditional lethal mutants for immunization in viral infections.
    Fenner F
    Adv Exp Med Biol; 1972; 31(0):131-44. PubMed ID: 4672020
    [No Abstract]   [Full Text] [Related]  

  • 40. What you should know about new and current viral vaccines.
    Weibel RE
    Mod Med Asia; 1978 Jun; 14(6):28-34. PubMed ID: 207966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.